NYSE · Chemicals · USD
Braskem S.A. (BAK) Stock Analysis
Braskem S.A. (BAK) is a Chemicals stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
BAK Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.67
- Previous Close
- $1.67
- Day's Range
- 1.61–1.71
- 52-Week Range
- 1.40–5.40
- Volume
- 1.79M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.67
Valuation
- Market Cap
- $733.21M
- P/E Ratio
- unprofitable
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.46
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −2.60
Financials (FY)
- Revenue (FY)
- $70.72B−8.65%
- Net Income (FY)
- −$9.88B
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −7.85%
- Shares Outstanding
- 172.53M
- 1-Year Return
- −33.33%
Dividend and dates
- Earnings Date
- November 12, 2026
- Avg Volume
- 2.13M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, BAK closed at $1.64, −33.33% over 1 year.
Braskem S.A. (BAK) has a market capitalization of $733.21M.
In fiscal 2025, BAK reported revenue of $70.72B.
BAK Stock Return by Calendar Year
Braskem S.A. (BAK) 10-year return: what $10,000 became
- 1 year
- $10,000 $6,667
- −33.33%
- 5 years
- $10,000 $963
- −90.37%
- 10 years
- $10,000 $1,195
- −88.05%
If you had invested $10,000 in Braskem S.A. (BAK) 10 years ago, at the close on October 21, 2016, it would have been worth $1,195 at the close on October 21, 2026: −88.05% in total, −19.14% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −44.41% |
| 2025 | −23.58% |
| 2024 | −56.24% |
| 2023 | −4.13% |
| 2022 | −54.75% |
| 2021 | +167.18% |
| 2020 | −39.12% |
| 2019 | −37.81% |
| 2018 | −2.63% |
| 2017 | +27.42% |
| 2016 (partial year) | +69.66% |
As of October 21, 2026.
BAK Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $70.72B | −$9.88B | −14.0% |
| 2024 | $77.41B | −$11.32B | −14.6% |
| 2023 | $70.57B | −$4.58B | −6.5% |
| 2022 | $96.52B | −$336.00M | −0.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $70.72B | $1.56B | −$1.64B | −$9.88B | −14.0% |
| 2024 | $77.41B | $6.00B | −$990.00M | −$11.32B | −14.6% |
| 2023 | $70.57B | $3.02B | −$1.75B | −$4.58B | −6.5% |
| 2022 | $96.52B | $11.36B | $6.11B | −$336.00M | −0.3% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
BAK Dividend History
Dividends per share, 2022 · 1 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2022 | $0.67 | 1 | −75.1% |
| 2021 | $2.71 | 1 | — |
| 2019 | $0.41 | 1 | −63.5% |
| 2018 | $1.11 | 1 | +43.1% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2022 | $0.67 | 1 | −75.1% |
| 2021 | $2.71 | 1 | — |
| 2019 | $0.41 | 1 | −63.5% |
| 2018 | $1.11 | 1 | +43.1% |
| 2017 | $0.78 | 1 | — |
Most recent payment: $0.67 per share, ex-dividend April 20, 2022. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
BAK Valuation vs Chemicals Median
Median of 16 stocks| Metric | BAK | Chemicals median | vs median |
|---|---|---|---|
| P/S ratio | 0.01 | 0.29 | 0.0x the median |
| Profit margin | −7.85% | −2.65% | 5.2 pts below |
Medians across 16 Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Braskem Strengthens Industrial Cybersecurity with SecureOT Platform by Rockwell Automation
YahooBraskem S.A. - Depositary Receipt Price Target Decreased by 25.51% to $2.94
FintelPetrobras' Braskem Exposure Faces Test as Debt Talks Continue
YahooHSBC Downgrades Braskem to Hold, Lowers Price Target to $1.5
BenzingaUpdate: Market Chatter: Petrobras Executive Expects Braskem to Finalize Deal With Creditors
YahooUpdate: Market Chatter: Braskem Creditors Seek $3 Billion Capital Injection From Controlling Holders
Yahoo
All 12 articles ↓Show fewer ↑
Transcript: Braskem Q2 2026 Earnings Conference Call
BenzingaUBS Downgrades Braskem to Sell, Lowers Price Target to $1.5
BenzingaBraskem: The Business Is Worth Saving, The Stock Is Anyone's Guess
SeekingAlphaBraskem S.A. (BAK) Q2 2026 Earnings Call Transcript
SeekingAlphaBraskem S.A. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaBraskem: 3-Year Update, But I Am Dubious (Rating Downgrade)
SeekingAlpha
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Chemicals Stocks
Dow Inc.
$21.94B
MX.TOMethanex Corporation
CA$6.87B
CECelanese Corporation
$4.91B
OLNOlin Corporation
$1.70B
HUNHuntsman Corporation
$1.44B
REXREX American Resources Corporation
$1.35B
Popular Basic Materials Stocks
Linde plc
$230.75B
BHPBHP Group Limited
$211.50B
SCCOSouthern Copper Corporation
$167.24B
RIORio Tinto Group
$141.37B
NEMNewmont Corporation
$123.47B









